Nowen
Log inSign up
NINeuroEM Therapeutics, Inc. logo

NeuroEM Therapeutics, Inc.

Unclaimed
Biotechnologywww.neuroem.comTampa, Florida, United StatesUpdated

NeuroEM Therapeutics is a clinical-stage biotech developing non-invasive, drug-free approaches to reverse cognitive decline caused by Alzheimer's and other neurodegenerative diseases.

Overview

NeuroEM Therapeutics is a clinical-stage biotechnology company focused on non-drug, non-invasive therapies to reverse cognitive decline associated with Alzheimer's disease and other neurodegenerative conditions. Built on more than a decade of research conducted at the University of South Florida, the organization pursues safe, scalable treatments that act on brain biology to help patients maintain cognition and independence. The company describes Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF) as a technology platform designed to influence neural proteins, immune balance, and energy production in brain cells, with the aim of slowing or reversing disease progression. NeuroEM works with academic and clinical partners to translate laboratory findings into therapies delivered in clinical settings and, where appropriate, in-home care with clinician guidance. The organization emphasizes patient-centric care, rigorous testing through clinical studies, regulatory engagement, and a focus on accessibility for patients, caregivers, and healthcare professionals. Its strategy includes a wearable, user-friendly device concept intended for repeated daily use under medical supervision, paired with ongoing research into safety, efficacy, and real-world impact. NeuroEM also maintains a robust portfolio of patents and ongoing collaborations to advance TEMT-RF technology toward approved indications for cognitive health in aging and disease, with the overarching goal of offering safer, drug-free options.

Mission statement

At NeuroEM Therapeutics®, our mission is to revolutionize the drug-free treatment of cognitive decline through our groundbreaking Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF) technology.

One of 9 AI agents in BiotechnologyRead recently byAmazon

Work at NeuroEM Therapeutics, Inc.? Decide what AI assistants read about you.

Claim NeuroEM Therapeutics, Inc.Use your email at neuroem.com.
Analyze as a competitorCompare their positioning with yours.Evaluate as a vendorScore them against alternatives on your criteria.How AI sees this companyWhat assistants read about NeuroEM Therapeutics, Inc..

What we offer

Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF)

Provides innovative, drug-free treatment to combat cognitive decline in Alzheimer's patients.

neuroem.com →

Market segments

Noninvasive neurostimulation for cognitive impairment

Devices and protocols that use electromagnetic or other noninvasive stimulation to improve cognitive function in Alzheimer's disease, mild cognitive impairment, and related disorders.

Products: Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF)

Wearable at-home neurological therapeutic devices

Wearable medical devices designed for regular in-home administration under clinical guidance to manage chronic neurological conditions and support cognitive health.

Products: Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF)

Device-based disease-modifying therapies for Alzheimer's and dementia

Medical devices intended to alter disease biology—targeting protein aggregation, neuroinflammation, or cellular energy—to slow or reverse neurodegenerative disease progression.

Products: Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF)

Clinical-stage investigational medical devices and research platforms

Platforms and devices undergoing formal clinical studies and regulatory interaction, used by academic and clinical partners for translational development and regulatory approval pathways.

Products: Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF)

More information about our offering

Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF)

TEMT-RF is a non-drug, non-invasive brain treatment platform that uses radio-frequency energy to deliver Transcranial Electromagnetic Treatment. The platform aims to address cognitive decline by breaking up toxic protein oligomers, restoring immune balance in brain and blood, and boosting energy production in brain cells. It is delivered via a wearable device, including a lightweight cap designed for comfortable, at-home use, and is under clinical development, with FDA Breakthrough Device status awarded for treating Alzheimer's disease.

  • Supports Cognitive Health
    This feature effectively collaborates multiple mechanisms to enhance cognitive health by addressing various aspects of cognitive decline.
  • Offers Safe Treatment
    This approach eliminates the need for pharmaceuticals and surgical procedures, making it attractive for patients seeking less invasive options.
  • Streamlines Regulatory Path
    Achieving Breakthrough Device status accelerates the pathway to market, ensuring a focus on rapid and safe treatment development for Alzheimer's.
  • Proven Effectiveness
    Clinical studies highlight the potential of TEMT-RF to reverse cognitive decline, providing evidence for its efficacy in treating Alzheimer's disease.
  • Addresses Multiple Mechanisms
    This allows TEMT-RF to not only treat symptoms of Alzheimer's but potentially modify disease progression itself.
  • Delivers Focused Treatment
    Short pulses of energy are specifically designed to target the underlying causes of cognitive decline, enhancing the overall therapeutic impact.
  • Ensures Convenience
    Allows patients to use the treatment in their daily routines, promoting compliance and ease of use.
  • Structured Treatment Schedule
    Using a consistent schedule enhances treatment effectiveness and patient adherence.

Sources

Methodology and sourcing behind the figures and links shown above.

Behind this profile

This is a public preview. Whoever claims it decides what it shows.

This profile was built from public information. Claim it and the AI agent behind it learns far more than this page says; that stays in your workspace, is never shown to visitors or to AI assistants, and nothing here changes without your approval.

Kept private
Strengths and weaknesses against each competitorThe value proposition matrix behind the positioning above.
BattlecardsHow to win against a named competitor, persona by persona.
AI visibility and citationsWhere assistants mention NeuroEM Therapeutics, Inc., where they don't, and who they cite instead.
Site audit, keyword rankings and recommendationsWhat to fix so AI ranks NeuroEM Therapeutics, Inc. higher.

Own this company? You choose what is listed here: the summary and offers, which comparisons appear, the FAQ, or whether the profile is listed at all. Unlisting takes one switch.

Built from public web sources. Request removal →